Cukurova University
Adana, Sarıçam, 01380, Turkey (Türkiye)
NCT Number: NCT02848963
ASA I-II 3-12 years old children participated to this study. All Participants will divide into the three groups. In Groups I, 2,5 mg/kg propofol and 0,5 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 5/1 ratio of ketamine-propofol mixture with %67 of Mcfarlan dose regiment.
In Groups II, 2,75 mg/kg propofol and 0,41 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 6,7/1 ratio of ketamine-propofol mixture with %80 of Mcfarlan dose regiment.
In Groups III, 3 mg/kg propofol and 0,3 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 10/1 ratio of ketamine-propofol mixture with %90 of Mcfarlan dose regiment.
After than surgical operation recovery time, PAED scores, FLACC scores, Staying time in PACU will be recorded. These data will be evaluated with statistically.
Looking for future studies?
Notify Me3 year–12 year
All sexes
Interventional
Phase 4
Adana, Sarıçam, 01380, Turkey (Türkiye)
ASA I-II, 3-12 years old children who will operate due to tonsillectomy and adenoidectomy. will be participated in to this study. All Participants will divide into the three groups. In Groups I, 2,5 mg/kg propofol and 0,5 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 5/1 ratio of ketamine-propofol mixture with %67 of Mcfarlan dose regiment.
In Groups II, 2,75 mg/kg propofol and 0,41 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 6,7/1 ratio of ketamine-propofol mixture with %80 of Mcfarlan dose regiment.
In Groups III, 3 mg/kg propofol and 0,3 mg/kg ketamine will apply at anaesthesia induction. General anaesthesia will be performed with 10/1 ratio of ketamine-propofol mixture with %90 of Mcfarlan dose regiment.
McFarlan dose regiments include 15 mg/kg/h infusion during 15 minutes, 13 mg/kg/h infusion during second 15 minutes, 11 mg/kg/h infusion from 30 to 60 minutes, 10 mg/kg/h from 1 to 2 h.
Anaesthesia dept will be detect with BIS monitoring during operation. After than surgical operation recovery time, PAED scores, FLACC scores, staying time in PACU and extubation time will be record. At the end of the study, these data will be evaluated with statistically.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ratio of Ketamine-propofol mixture will be compare for every groups.
Other names: ketofol
Time frame: During 1 hour at post operative period
All patients will be evaluate with PAED scores at PACU during first 1 hour
Time frame: During peroperative period.
All Patients will monitored with BIS monitoring during operation.
Time frame: time from injection of reversal to extubation, through patient extubated
At the end of the surgery, time from injection of reversal to extubation
Time frame: During 1 hour at post operative period
All patients will be evaluate with FLACC scores at PACU during first 1 hour
Cukurova University
Other
Effect of Ketamine-propofol Mixture on Postoperative Pain and Sedation-agitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07568093
Aberrant Motor Behavior in Dementia, Agitation
Hanover, Lower Saxony, Germany
View Trial DetailsNCT07619326
Aberrant Motor Behavior in Dementia, Agitation
Changhua, Taiwan
View Trial DetailsNCT04268303
Aberrant Motor Behavior in Dementia, Agitation
Little Rock, Arkansas, United States
View Trial DetailsNCT03317067
Aberrant Motor Behavior in Dementia, Agitation
Clermont-Ferrand, France
View Trial Details